PT Medikaloka Hermina Tbk (IDX:HEAL)
Indonesia · Delayed Price · Currency is IDR 515.00
0.00 (0.00%)
Oct 30, 2026, 4:14 PM WIB
PT Medikaloka Hermina Tbk Financials Overview
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 7,368,562 | 7,133,538 | 6,717,179 | 5,784,086 | 4,901,810 | 5,869,014 |
Revenue Growth | 5.59% | 6.20% | 16.13% | 18.00% | -16.48% | 32.90% |
Gross Profit Gross Profit Growth | 2,456,054 | 2,281,170 | 2,322,780 | 1,920,245 | 1,568,808 | 2,783,140 |
Operating Income Operating Income Growth | 906,257 | 968,533 | 1,059,504 | 817,470 | 587,944 | 1,765,040 |
Net Income Net Income Growth | 376,848 | 429,547 | 535,942 | 437,346 | 298,596 | 995,974 |
Earnings Per Share EPS Growth | 24.62 | 28.40 | 36.11 | 29.73 | 20.29 | 66.80 |
EPS Growth | -12.84% | -21.35% | 21.46% | 46.52% | -69.63% | 110.14% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 628,772 | 727,793 | 643,168 | 855,643 | 775,388 | 1,286,844 |
Total Debt Total Debt Growth | 3,694,085 | 3,225,366 | 3,238,756 | 2,260,897 | 1,737,351 | 1,666,533 |
Net Cash (Debt) Net Cash Growth | -3,065,313 | -2,497,573 | -2,595,588 | -1,405,254 | -961,963 | -379,689 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -200.24 | -165.14 | -174.88 | -95.51 | -65.38 | -25.47 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,427,706 | 1,137,838 | 1,137,623 | 1,319,655 | 867,738 | 1,856,336 |
Capital Expenditures CapEx Growth | -1,387,849 | -1,749,989 | -2,281,991 | -1,591,362 | -1,129,010 | -1,213,544 |
Free Cash Flow Free Cash Flow Growth | 39,857 | -612,151 | -1,144,368 | -271,707 | -261,272 | 642,792 |
Free Cash Flow Growth | - | - | - | - | - | 171.41% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 33.33% | 31.98% | 34.58% | 33.20% | 32.01% | 47.42% |
Operating Margin | 12.30% | 13.58% | 15.77% | 14.13% | 11.99% | 30.07% |
Pretax Margin | 9.32% | 10.58% | 13.50% | 12.28% | 9.79% | 28.05% |
Profit Margin | 5.11% | 6.02% | 7.98% | 7.56% | 6.09% | 16.97% |
FCF Margin | 0.54% | -8.58% | -17.04% | -4.70% | -5.33% | 10.95% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 13.500 | - | 10.500 | 8.500 | 7.000 | 6.000 |
Dividend Per Share Growth | 28.57% | - | 23.53% | 21.43% | 16.67% | 20.00% |
Dividend Yield | 2.62% | - | 0.64% | 0.57% | 0.45% | 0.56% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.92 | 49.19 | 45.29 | 49.60 | 75.08 | 15.77 |
Forward PE | 15.82 | 34.23 | 34.94 | 36.69 | 42.12 | 21.13 |
P/FCF Ratio | 196.99 | - | - | - | - | 24.43 |
PS Ratio | 1.07 | 2.96 | 3.61 | 3.75 | 4.57 | 2.68 |